Biogen has licensed another experimental drug from its longtime development partner Ionis Pharmaceuticals, bringing in house a treatment the companies believe could offer some advantages over their blockbuster medicine Spinraza.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,